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INTRODUCTION
The Coronavirus Disease 2019 (COVID-19) pandemic is affecting
healthcare systems and resources around the world in an unprece-
dented manner. Based on recommendations from the numerous
medical specialty societies and governmental agencies such as the
United States Centers for Disease Control and Prevention1 and Cen-
ters for Medicare & Medicaid Services2, non-urgent procedures and
tests were either canceled or postponed during the buildup to and
decline from the pandemic’s peak. The American Society of Nuclear
Cardiology (ASNC) and the Society of Nuclear Medicine and Mo-
lecular Imaging (SNMMI) issued an Information Statement3 with
guidance for nuclear cardiology laboratories during the COVID-
19 pandemic in late March 2020 that also recommended delaying
all non-urgent studies. Reestablishment of non-emergent care4 in
nuclear cardiology laboratories will require a careful approach to
continue to mitigate the risk of viral transmission while also pro-
viding crucial cardiovascular assessments for our patients. The
current document prepared by ASNC, SNMMI, the International
Atomic Energy Agency (IAEA) and the Infectious Disease Soci-
ety of America (ISDA) describes potential practices for this rees-
tablishment, reflecting diverse settings from the United States and
worldwide.
It is important to note that these recommendations are primarily
based on expert opinion, not systematically tested, and may pro-
vide guidance to supplement guidelines, regulations and legisla-
tion as well as institutional infection control policies.2 A survey of
the authors’ opinions regarding several issues outlined in this doc-
ument is available in the online supplement (supplemental materials
are available at http://jnm.snmjournals.org).
GENERAL PRINCIPLES
A. Timing of Re-Opening/Resuming Activities in
Stress/Nuclear Cardiology Laboratory:
1. Timing should follow national, state and local regulations and
recommendations.4–6
2. Healthcare facilities should have adequate equipment and per-
sonnel and not be in crisis management mode or diversion
mode. For inpatient laboratories, there should be available hos-
pital beds and intensive care unit beds.
3. In general, we recommend that utilization of nuclear cardiology
services parallel opening of upstream and downstream resources
such as clinics, catheterization laboratories, operating rooms and
other services, so as to facilitate uniform care delivery.
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B. COVID-19 Testing:
The diagnosis of COVID-19 is based on the detection and iden-
tification of the virus by means of the reverse transcription poly-
merase chain reaction (RT-PCR), a molecular diagnostic technique
based on the detection of specific genetic sequences of the virus.
Antibody tests detect immunoglobulin antibodies from an immune
response to SARS-CoV-2 and are not appropriate for diagnosing
current COVID-19 infection. Laboratories should rely on molec-
ular tests to diagnose the presence of SARS-CoV-2 infections.
However, a negative molecular test result does not rule out
COVID-19 for several reasons. Some patients may have negative
initial tests due to low viral load during the early days of infection
or inadequate sampling of the posterior nasopharynx. Thus, social
distancing and PPE are critical to prevention of laboratory
transmission of COVID-19. When testing capacity allows, using
a molecular test to test for COVID-19 infection prior to appoint-
ments in the nuclear cardiology laboratory is recommended
combined with screening patients for a fever and symptoms con-
sistent with COVID-19 infection upon arrival for testing appoint-
ments. Patients who are known to have an active infection with the
COVID-19 virus should in the vast majority of cases have their
nuclear cardiology test deferred.
C. Preventive Measures for COVID-19 Disease:
The implementation of preventive and mitigation measures is
essential. The most effective preventive measures include perfor-
mance of proper hand hygiene; avoidance of touching eyes, nose
and mouth; practice respiratory hygiene when coughing or
sneezing; wearing a medical mask and maintenance of physical
distancing (ideally 2 meters or more).8,9
D. Personal Protective Equipment (PPE):
The goal of PPE use is to protect healthcare providers and
patients and predominantly to minimize spread from asymptom-
atic individuals and surface exposure.10 Healthcare workers re-
quire additional precautions to protect themselves and prevent
transmission in the healthcare environment. Precautions in-
clude wearing proper PPE and donning and doffing items prop-
erly. Recommendations for PPE use vary by institution, region
and country and the type of PPE recommended will usually be
based on institutional or regional policies. Currently most
healthcare centers in the United States require universal use
of a surgical mask by staff and visitors with selective use of
more advanced PPEs. As nuclear cardiology and other labora-
tories re-expand their operations, a sufficient and increasing
quantity of PPE will be required for protection for healthcare
personnel and patients. PPE use is currently recommended
throughout the nuclear laboratory when indicated; this use
should follow national, state/regional, and local public health
policies and recommendations.
SPECIFIC PRINCIPLES FOR NUCLEAR CARDIOLOGY
A. Before the Test:
1. Prioritization of a Study Request: As we move into the next
phase of the COVID-19 pandemic, in which newly diagnosed
cases have declined in many regions, regulations are permitting
flexibility and allow facilities to reinstate services for patients
needing non-emergent non-COVID-19 care. Urgent patients should
continue to be tested first and as quickly as prudently possible
while ensuring patient and healthcare provider safety. It is
important to remember that many of the patients with higher
priorities are typically symptomatic whose risk of a cardiac event
is not insignificant.
• For patients of equal urgency, those who have been waiting
the longest for their procedure should be the first to undergo
testing.
• Many patients have had testing delayed for several weeks
during the period of sheltering in place; it is important for
the provider team to maintain contact with patients and to
encourage them to report changes in symptoms.
• Due to the delay in testing, extra caution needs to be exer-
cised by clinical staff, including supervising physicians, as
the patient’s clinical status may have deteriorated to the point
where stress testing may no longer be safe or appropriate.
• For some patients requiring prior approval from the insurance
carrier, the approval may have expired and need to be re-
instated. However, some Radiology Benefit Management
companies in the United States have recently extended the
time period before expiration during the pandemic.
• Case prioritization can be performed primarily by laboratory
professionals but is most commonly decided collectively and
in collaboration with other colleagues from cardiology, sur-
gery, and other disciplines.
• Early during the COVID-19 pandemic, many facilities prior-
itized patients being scheduled and those already scheduled
according to the perceived clinical urgency of the study.
Please see an example of a prioritization scheme using four
categories in Table 1. Some laboratories use a 3-category
scheme instead.3
2. Scheduling a Patient: Scheduling of patients should take into
account a number of parameters including institutional and labo-
ratory resources for safe performance of testing during the COVID-19
pandemic.
• Institutional policies: When increasing patient volume
through the nuclear cardiology laboratory, it is also important
that this be coordinated with the affiliated institution to en-
sure that service delivery is consistent with their overarching
plan during the pandemic.
• Staff: Availability of laboratory staff is an equally important
consideration, especially if many have been redeployed, fur-
loughed or become ill as a result of the pandemic.
• Operating hours: As utilization increases, laboratories should
consider extending to early/late hours and/or weekend testing
to allow the backlog of patient tests to be completed and to
allow more effective social distancing. This approach should
be balanced with availability of staff and key equipment, espe-
cially PPE.
• Phased opening: A phased opening with a ramp up period is
generally recommended by health agencies2. For example,
25% of a standard case load might be planned for the first
1–2 weeks, 50% case load in weeks 3 and 4, and then greater
caseloads if conditions permit. Concomitant overlapping
cases should be avoided to provide for appropriate social
distancing.
• Adequacy of supplies: To reestablish operations it is neces-
sary to ensure the availability of radioisotopes which are pro-
duced in a limited number of facilities worldwide. One of the
effects of the pandemic has been the disruption of distribution
channels, including international cargo flights. In addition,
many radiopharmacies have either furloughed or laid off staff
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because of reduced demand over the period of sheltering in
place during the pandemic.
• Resources: In addition, the laboratory needs to ensure that
they have adequate resources to safely perform testing, keep-
ing in mind that the demand for certain equipment will grow
as other healthcare providers ramp up deferred services.
• Communication/patient concerns: A significant proportion of
patients may decline testing because of concerns about the
risk of contracting COVID-19 by visiting the testing facility.
Institutions must provide referring physicians detailed infor-
mation about steps taken by the laboratory to minimize the
risk of COVID-19 infection. Referring providers must remind
patients about the real and significant risk of not undergoing
testing. Staff scheduling patients should have scripting avail-
able to screen patients for symptoms consistent with COVID-19
to reassure patients, including a description of the additional
precautions that are being undertaken by the laboratory
to minimize COVID-19 infection risk. If a patient refuses
to undergo testing it is of the utmost importance for the
nuclear cardiology laboratory to inform the referring physi-
cian to let them know of the patient’s decision so that they
can contact the patient to discuss this further and make alter-
nate arrangements.
• Tracking: Establishment of proper systems to track canceled
or postponed studies is very important. Providers should es-
tablish a priority score that can include indication for testing
and overall CV risk, and COVID-19 risk.
B. Day of Testing:
Specific precautions are recommended on the day of the test at
the time of arrival, during the imaging test and during the stress
test to minimize COVID-19 exposure risk as outlined below. An
important principle is to minimize the amount of time spent by
patients in the nuclear cardiology laboratory or at the associated
institution to reduce risk both for patients and staff.
1. Arrival/Registration: A key goal is to avoid overcrowding of
the elevators, waiting rooms, corridors, and scanners while not
delaying patient care. The test procedures need to allow for
adequate social distancing between patients before and during the
whole testing process.
• Appropriate physical distancing should be maintained at all
stages of patient engagement, including registration, waiting
areas, and consent. Waiting areas and processes should be
arranged to allow appropriate physical distancing. In addi-
tion, accompanying visitors and family members should not
be allowed or should be limited to one person and only if
their presence is essential. If the facility has significant space
constraints, consideration should be to having patients wait in
their vehicles until contacted by cellphone by a member of
the nuclear cardiology laboratory staff. The patient would
then be met at the entrance of the facility by the staff member
and escorted to the laboratory.
• The use of telehealth to assess patients for new symptoms, to
register the patient, to provide them with details about the test
to be performed, and to obtain verbal consent is generally
recommended. Processes should also be automated as much
as possible to reduce face to face interaction. Some onsite
administrative steps can be performed through the patient’s
smartphone. The healthcare screening questionnaire should
be thorough.
• Temperature measurements and a screening questionnaire for
all patients are generally recommended at arrival to health-
care facility and to nuclear laboratory.
• Face covering or masks are currently mandated at most med-
ical centers (surgical/cloth/specific mask type as determined
by local rules and infection control) for all patients, visitors,
and healthcare personnel.
• Review indication for testing at registration or immediately
upon a patient’s arrival in clinical areas to ensure that the test
is still indicated and urgent. Changes in symptoms and/or
health status may either render the test not indicated or de-
mand a different test.
2. Imaging Considerations: The overarching goals are to per-
form rapid and hygienic imaging to minimize COVID-19 expo-
sure to healthcare professionals and patients.
a. Protocol selection
• For SPECT myocardial perfusion imaging studies, elect
stress first/stress only imaging when possible to potentially
decrease duration of the study, and consider rapid acquisition
protocols when feasible.
• For SPECT myocardial perfusion imaging studies in inpa-
tients who are not eligible for stress only testing, consider
performing the rest injection in the patient’s inpatient room,
to avoid completely or minimize waiting time in the labora-
tory. A typical protocol would begin with a technologist
bringing a dose of technetium-99m sestamibi or tetrofosmin
to the patient’s inpatient room, checking the intravenous line,
and injecting the dose. After a suitable delay, the patient is
transported to the laboratory, directly to a waiting open cam-
era, where rest imaging is performed. After an appropriate
delay, when the patient waits in their hospital room, he or she
is brought to an open stress room where stress testing is
performed. After stress testing, the patient is transported back
TABLE 1
An Example of a Prioritization Scheme
Urgent inpatient or outpatient (to be performed upon
request): Inpatient or outpatient with a clinical scenario
suggesting a moderate to high likelihood of short-term
major adverse cardiac events, in whom the results of
testing would have high likelihood of modifying
management
Higher priority (deferred for 1–2 months): Inpatient or
outpatient who meets AUC criteria for testing, but with a
clinical scenario suggesting a low likelihood for short-term
major adverse cardiac events
Lower priority (deferred for 2–4 months): Outpatient, who
meets AUC criteria for testing, and who is clinically stable,
expected to have normal or low-risk findings that would
not be expected to affect short-term management. Some
examples are pre-operative testing for elective surgery;
surveillance testing such as in asymptomatic patients with
prior history of PCI or CABG, a patient already on class
1C antiarrhythmic, a patient post cardiac transplant;
asymptomatic patient with an elevated coronary artery
calcium score
Elective (deferred for 4–6 months): Screening or wellness
tests such as coronary artery calcium scans and treadmill
exercise tests
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to their room, and returns to a waiting open camera approxi-
mately 1–1.5 hours after stress injection.
• For technetium-99m pyrophosphate (PYP) scans in inpa-
tients, consider injecting the patient and allowing him/her
to leave the laboratory, returning for imaging after the labo-
ratory protocol delay.
• For N-13 ammonia PET myocardial perfusion imaging stud-
ies, consider performing a protocol facilitating a single rest/
stress session on the camera with enhanced social distancing,
and avoid the patient leaving the camera room between rest
and stress sessions and the camera needing cleaning multiple
times. A low-dose rest, high-dose stress protocol may enable
a more rapid single-session imaging.
b. Imaging time slots may need to be expanded and extra time
should be allowed for cleaning rooms, cameras, chairs, and
other surfaces between patients.
c. Appropriate cleaning of equipment between cases is essential.
d. For outpatients requiring rest imaging, consideration could
also be given to performing this on a separate day to give
greater control of workflow and minimize time within the
department, although this approach may be less appropriate
in some settings and needs to be balanced by the downside of
using more PPE for 2-day imaging.
e. For laboratories with access to myocardial perfusion PET
using Rb82, this modality is preferred because of its time
efficiency. A complete rest-stress PET MPI study can be
acquired within 30 to 45 minutes, not only minimizing ex-
posure for patients and staff, but also potentially reducing
number of rooms and spaces which could experience surface
contamination and possibly reducing staffing needs.
f. For patients tested with SPECT-CT or PET-CT instrumenta-
tion in regions with higher prevalence of COVID-19 infec-
tions, some laboratories recommend a policy of reviewing
the chest CT images before the patient leaves the laboratory.
For patients who have lung infiltrates seen on chest CT im-
ages, they may require further evaluation for possible
COVID-19 infection.12
3. Stress Laboratory Considerations: The goals are to perform
a safe test for the patient and minimize droplet exposure to
healthcare professionals and patients.
• If possible, consider pharmacologic testing preferably using
vasodilator stress agents to decrease droplet exposure risk,9
especially in patients who are not known to be COVID-19
negative. Patients breathing heavily during exercise may gener-
ate droplets and traditionally stress test personnel are in close
proximity to patients. Pharmacologic testing is not inferior to
exercise testing in terms of diagnostic performance. Regadeno-
son may be the preferred stress agent (if available and not
contraindicated), since it requires a single 10 second infusion,
after which providers can maintain a safe distance from the
patient. For adenosine and dipyridamole stress testing, extra-
long tubing can be used to keep distance between staff and
patients.
• If after careful consideration, exercise testing is determined
to be necessary, it is recommended to use a higher-level PPE
for staff (for example N95/FFP2/P2/DS/KN95/Korea 1st class
respirator or equivalent, face shield, gloves and gown) and
surgical mask or face covering for patients, assuming these
supplies are available,11 and extra time should be allowed in
order to clean the room.
• Appropriate cleaning between patients is required.
ONGOING CONSIDERATIONS FOR THE LABORATORY
An important goal of an ongoing monitoring process is to refine
policies and procedures as needed in response to the evolution of
the COVID-19 pandemic as the laboratory operations resume to
include more elective procedures.
A. Additional data collection and monitoring may be warranted.
The nuclear cardiology laboratory’s protocols and patient
scheduling templates will need to be closely monitored and
refined multiple times over the coming months as the COVID-
19 pandemic slowly recedes, with potential for local or wide-
spread waves of new COVID-19 infections. Data collection and
monitoring will be necessary to inform the need to modify
existing laboratory policies. Some suggested parameters for
collecting and monitoring and potential responsive changes to
laboratory workflow are listed in Table 2.
B. Availability of laboratory personnel might be impacted by
redeployment to other work responsibilities in the healthcare
system during the COVID-19 pandemic, staff quarantine to
home due to COVID-19 infection of the staff or their close
contacts, and other non-COVID-19 related issues.
C. Laboratory testing hours should be adjusted as needed.
• Expansion of testing might need to be suspended completely
if essential laboratory personnel are unavailable. Similarly, if
the supply of PPE or COVID-19 testing is interrupted, test
scheduling would need to be reduced to allow for adequate
supply of PPE and COVID-19 testing for other patient care
areas of higher priority.
• If, however, there is a large backlog of orders for nuclear
cardiology procedures as a result of deferred testing during
the height of the COVID-19 pandemic, laboratories might
need to consider temporarily extending weekday hours of
operation or weekend testing to accommodate a surge in pa-
tient volume. The feasibility of extending hours of operation
TABLE 2
Workflow Parameters to Monitor in the Nuclear Cardiology Laboratory
Parameter for monitoring Impact on laboratory policies
Decreased laboratory personnel availability Reduce hours of operation
Decreased availability of PPE and COVID-19 testing Reduce hours of operation
Increased test duration (including cleaning) Adjust the patient scheduling template
Increased or pending orders for cardiac imaging procedures Increase hours of operation
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will depend of the availability of laboratory personnel,
PPE, and COVID-19 testing.
D. Tracking of total time required for nuclear cardiology
procedures is desirable. This includes time required to
fully clean and disinfect the stress testing equipment
and the imaging equipment. This information will in-
form patient scheduling templates.
SAFETY AND RISK FOR POTENTIAL SECOND OR
SUBSEQUENT WAVES
While one cannot predict the potential for a second or subse-
quent waves of COVID-19 pandemic, numerous public health
authorities are warning that it is possible, and procedures need to
be in place to mitigate the adverse effects of a second wave.
Hence, it is important to follow the steps below:
• Providers and institutions should monitor local data and fol-
low national, state, and department of public health recom-
mendations for possible second COVID-19 waves that may
require decreasing nuclear cardiology laboratory activities
and enhanced protective measures.
• Physical distancing and masking should be maintained for the
foreseeable future.
• Limitations on visitors and accompanying persons should be
continued for the foreseeable future as well.
NUCLEAR CARDIOLOGY TRAINING AND EDUCATION
Trainees are an important part of nuclear cardiology programs and
laboratories. During the COVID-19 pandemic, many trainees have
been redeployed from their imaging rotations to clinical care of
COVID-19 patients in the hospital and intensive care units. If the
pandemic continues, trainee education needs to be revised to use
novel training methods including web and video-based approaches
to learning. New educational procedures need to be consistent with
policies from stakeholders such as the Accreditation Council for
Graduate Medical Education, American Board of Internal Medicine,
American Board of Nuclear Medicine, American Board of Radiol-
ogy, and Nuclear Regulatory Commission. This is particularly
pertinent for hands-on education in the stress laboratory, hot
laboratory, and radiopharmacy, which may need to be adapted to
video methods. The number of cases required for graduation may
need to include a larger percentage of virtual educational sessions, in
compliance/collaboration with certifying agencies including the
Certification Board of Nuclear Cardiology, American Board of
Internal Medicine, the American Board of Nuclear Medicine, and
the American Board or Radiology.
ADDITIONAL CONSIDERATIONS
• Staff should be monitored for wellbeing during these some-
times-stressful times, especially if required to work long
hours and if they are redeployed to unfamiliar areas.
• In the United States, nuclear cardiology services are often
impacted by the details of the patient’s health insurance pol-
icy and enforcement by radiology benefits managers. More
advocacy effort will be required to convince these oversight
agencies to allow relaxation of previous policies on prior
authorization and flexibility for longer approval windows
and to resist one-size-fits-all prescribed approaches.
• Laboratory leadership should consider redeployment of phy-
sician and nursing staff away from routine (elective) office
activities until backlog has been reduced, especially for
higher priority patients. This approach will help get the
higher risk patients whose tests have been deferred com-
pleted, while not adding more and more higher priority pa-
tients to the schedule.
• Nuclear cardiology laboratory operations, of course, are part
of the local healthcare systems and work in conjunction
with other departments in the hospital and areas of the
medical practice. Most of the suggestions outlined above
must be instituted in concert and collaboration with other
key departments.
CONCLUSIONS
The unprecedented COVID-19 pandemic has disrupted health-
care systems, including nuclear cardiology laboratories around the
world, severely reducing their services. As the health crisis recedes,
nuclear cardiology laboratories are able to gradually expand opera-
tions while maintaining appropriate safe practices. This document
lays out guidance about best practices, but it is important to recognize
that conditions are quite different in various locations and will change
in the coming months. An individualized, adaptable, and thoughtful
approach that coordinates with other providers and public health
authorities will be needed for the foreseeable future.
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